Early Endpoints for Acute Bacterial Skin and Skin Structure Infections

Por Drusano, George L.
Publicado em 2012

Mathematical Modeling of the Interrelationship of CD4 Lymphocyte Count and Viral Load Changes Induced by the Protease Inhibitor Indinavir

Por Drusano, George L., Stein, Daniel S.
Publicado em 1998

Dosing Regimen Matters: the Importance of Early Intervention and Rapid Attainment of the Pharmacokinetic/Pharmacodynamic Target

Por Martinez, Marilyn N., Papich, Mark G., Drusano, George L.
Publicado em 2012

Pharmacodynamic Evidence that Ciprofloxacin Failure against Tuberculosis Is Not Due to Poor Microbial Kill but to Rapid Emergence of Resistance

Por Gumbo, Tawanda, Louie, Arnold, Deziel, Mark R., Drusano, George L.
Publicado em 2005

Impact of Resistance Selection and Mutant Growth Fitness on the Relative Efficacies of Streptomycin and Levofloxacin for Plague Therapy

Por Louie, Arnold, Deziel, Mark R., Liu, Weiguo, Drusano, George L.
Publicado em 2007

Telavancin Penetration into Human Epithelial Lining Fluid Determined by Population Pharmacokinetic Modeling and Monte Carlo Simulation

Por Lodise, Thomas P., Gotfried, Mark, Barriere, Steven, Drusano, George L.
Publicado em 2008

Optimizing Aminoglycoside Therapy for Nosocomial Pneumonia Caused by Gram-Negative Bacteria

Por Kashuba, Angela D. M., Nafziger, Anne N., Drusano, George L., Bertino, Joseph S.
Publicado em 1999

Interaction between Fluconazole and Amphotericin B in Mice with Systemic Infection Due to Fluconazole-Susceptible or -Resistant Strains of Candida albicans

Por Louie, Arnold, Banerjee, Partha, Drusano, George L., Shayegani, Mehdi, Miller, Michael H.
Publicado em 1999

Pharmacokinetic Determinants of Virological Response to Raltegravir in the In Vitro Pharmacodynamic Hollow-Fiber Infection Model System

Por Brown, Ashley N., Adams, Jonathan R., Baluya, Dodge L., Drusano, George L.
Publicado no Antimicrob Agents Chemother (2015)

The Relationship between Quinolone Exposures and Resistance Amplification Is Characterized by an Inverted U: a New Paradigm for Optimizing Pharmacodynamics To Counterselect Resista...

Por Tam, Vincent H., Louie, Arnold, Deziel, Mark R., Liu, Weiguo, Drusano, George L.
Publicado em 2007

Prediction of the Pharmacodynamically Linked Variable of Oseltamivir Carboxylate for Influenza A Virus Using an In Vitro Hollow-Fiber Infection Model System

Por McSharry, James J., Weng, Qingmei, Brown, Ashley, Kulawy, Robert, Drusano, George L.
Publicado em 2009

Chikungunya Virus: In Vitro Response to Combination Therapy With Ribavirin and Interferon Alfa 2a

Por Gallegos, Karen M., Drusano, George L., D′Argenio, David Z., Brown, Ashley N.
Publicado no J Infect Dis (2016)

Pharmacodynamics of Daptomycin in a Murine Thigh Model of Staphylococcus aureus Infection

Por Louie, Arnold, Kaw, Pamela, Liu, Weiguo, Jumbe, Nelson, Miller, Michael H., Drusano, George L.
Publicado em 2001

Phenotypic Drug Susceptibility Assay for Influenza Virus Neuraminidase Inhibitors

Por McSharry, James J., McDonough, Ann C., Olson, Betty A., Drusano, George L.
Publicado em 2004

Pharmacodynamic Profiling of Piperacillin in the Presence of Tazobactam in Patients through the Use of Population Pharmacokinetic Models and Monte Carlo Simulation

Por Lodise, Thomas P., Lomaestro, Ben, Rodvold, Keith A., Danziger, Larry H., Drusano, George L.
Publicado em 2004

Pharmacodynamics of Caspofungin in a Murine Model of Systemic Candidiasis: Importance of Persistence of Caspofungin in Tissues to Understanding Drug Activity

Por Louie, Arnold, Deziel, Mark, Liu, Weiguo, Drusano, Michael F., Gumbo, Tawanda, Drusano, George L.
Publicado em 2005

Pharmacodynamics of Cidofovir for Vaccinia Virus Infection in an In Vitro Hollow-Fiber Infection Model System

Por McSharry, James J., Deziel, Mark R., Zager, Kris, Weng, Qingmei, Drusano, George L.
Publicado em 2009

Pharmacokinetics and Absolute Bioavailability of Ribavirin in Healthy Volunteers as Determined by Stable-Isotope Methodology

Por Preston, Sandra L., Drusano, George L., Glue, Paul, Nash, Jacqueline, Gupta, S. K., McNamara, P.
Publicado em 1999

Pharmacokinetics and Pharmacodynamics of Cefepime in Patients with Various Degrees of Renal Function

Por Tam, Vincent H., McKinnon, Peggy S., Akins, Ronda L., Drusano, George L., Rybak, Michael J.
Publicado em 2003

Evaluation of Daptomycin Exposure and Efficacy and Safety Endpoints To Support Risk-versus-Benefit Considerations

Por Bhavnani, Sujata M., Ambrose, Paul G., Hammel, Jeffrey P., Rubino, Christopher M., Drusano, George L.
Publicado no Antimicrob Agents Chemother (2016)